Alendronate for Osteonecrosis in Adults With Sickle Cell Disease
Alendronate for Osteonecrosis in Adults With Sickle Cell Disease
Recruiting · NCT06016634 · Registry updated 2026-07-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Alendronate for Osteonecrosis in Adults With Sickle Cell Disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Legg-Calve-Perthes disease, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, anemia, avascular necrosis, bone disorder, familial avascular necrosis of femoral head, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, musculoskeletal system disorder, osteonecrosis, sickle cell disease | Recruiting | Phase 2 | 2026-07-16 | NCT06016634 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Doris Duke Charitable Foundation | 18 |
| National Heart, Lung, and Blood Institute (NHLBI) | 791 |
| University of California, Davis | 257 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| UC Davis Comprehensive Cancer Center | Sacramento | United States | 23 |